CN115246854B - Fluorescent probe for detecting mitochondrial hydrogen peroxide and preparation method and application thereof - Google Patents
Fluorescent probe for detecting mitochondrial hydrogen peroxide and preparation method and application thereof Download PDFInfo
- Publication number
- CN115246854B CN115246854B CN202211034998.8A CN202211034998A CN115246854B CN 115246854 B CN115246854 B CN 115246854B CN 202211034998 A CN202211034998 A CN 202211034998A CN 115246854 B CN115246854 B CN 115246854B
- Authority
- CN
- China
- Prior art keywords
- probe
- reaction
- mito
- dye
- target product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002438 mitochondrial effect Effects 0.000 title claims abstract description 45
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 title claims abstract description 36
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims abstract description 45
- 238000001514 detection method Methods 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 19
- 210000003470 mitochondria Anatomy 0.000 claims abstract description 15
- 239000007787 solid Substances 0.000 claims abstract description 8
- 238000004458 analytical method Methods 0.000 claims abstract description 6
- CBUOGMOTDGNEAW-UHFFFAOYSA-N 2-[4-(bromomethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(CBr)C=C1 CBUOGMOTDGNEAW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000010992 reflux Methods 0.000 claims abstract description 4
- 239000000975 dye Substances 0.000 claims description 42
- 239000000047 product Substances 0.000 claims description 29
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 17
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical group CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 claims description 8
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical group CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000012074 organic phase Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000011097 chromatography purification Methods 0.000 claims description 4
- 238000004440 column chromatography Methods 0.000 claims description 4
- 239000012043 crude product Substances 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000000799 fluorescence microscopy Methods 0.000 claims description 4
- 239000003208 petroleum Substances 0.000 claims description 4
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 4
- 238000011895 specific detection Methods 0.000 claims description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000000967 suction filtration Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 abstract description 74
- 230000015572 biosynthetic process Effects 0.000 abstract description 17
- 238000003786 synthesis reaction Methods 0.000 abstract description 17
- 230000035945 sensitivity Effects 0.000 abstract description 9
- 210000001519 tissue Anatomy 0.000 abstract description 7
- 230000008685 targeting Effects 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 2
- 238000001953 recrystallisation Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 41
- 238000012360 testing method Methods 0.000 description 18
- 238000005481 NMR spectroscopy Methods 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 238000003384 imaging method Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000005284 excitation Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 101100173048 Mus musculus Mcat gene Proteins 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 229920004890 Triton X-100 Polymers 0.000 description 6
- 239000013504 Triton X-100 Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- KBPLFHHGFOOTCA-UHFFFAOYSA-N caprylic alcohol Natural products CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000000684 flow cytometry Methods 0.000 description 6
- 238000004896 high resolution mass spectrometry Methods 0.000 description 6
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 6
- 238000006862 quantum yield reaction Methods 0.000 description 6
- 102000010909 Monoamine Oxidase Human genes 0.000 description 5
- 108010062431 Monoamine oxidase Proteins 0.000 description 5
- 239000003642 reactive oxygen metabolite Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 238000012752 Hepatectomy Methods 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 208000018737 Parkinson disease Diseases 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000010226 confocal imaging Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000008045 co-localization Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000005228 liver tissue Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000012679 serum free medium Substances 0.000 description 3
- PKYCWFICOKSIHZ-UHFFFAOYSA-N 1-(3,7-dihydroxyphenoxazin-10-yl)ethanone Chemical compound OC1=CC=C2N(C(=O)C)C3=CC=C(O)C=C3OC2=C1 PKYCWFICOKSIHZ-UHFFFAOYSA-N 0.000 description 2
- BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000702421 Dependoparvovirus Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 238000004847 absorption spectroscopy Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 2
- 238000004624 confocal microscopy Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- -1 superoxide anions Chemical class 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- BIWQNIMLAISTBV-UHFFFAOYSA-N (4-methylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1 BIWQNIMLAISTBV-UHFFFAOYSA-N 0.000 description 1
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- 102100028116 Amine oxidase [flavin-containing] B Human genes 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 101000768078 Homo sapiens Amine oxidase [flavin-containing] B Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000004103 aerobic respiration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- DLGYNVMUCSTYDQ-UHFFFAOYSA-N azane;pyridine Chemical group N.C1=CC=NC=C1 DLGYNVMUCSTYDQ-UHFFFAOYSA-N 0.000 description 1
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004791 biological behavior Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001085 differential centrifugation Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- HXITXNWTGFUOAU-UHFFFAOYSA-N dihydroxy-phenylborane Natural products OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000004993 emission spectroscopy Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical group O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 230000006705 mitochondrial oxidative phosphorylation Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- HGASFNYMVGEKTF-UHFFFAOYSA-N octan-1-ol;hydrate Chemical compound O.CCCCCCCCO HGASFNYMVGEKTF-UHFFFAOYSA-N 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012753 partial hepatectomy Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/10—The polymethine chain containing an even number of >CH- groups
- C09B23/105—The polymethine chain containing an even number of >CH- groups two >CH- groups
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1011—Condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1096—Heterocyclic compounds characterised by ligands containing other heteroatoms
Abstract
The invention discloses a fluorescent probe for detecting mitochondrial hydrogen peroxide, a preparation method and application thereof, and belongs to the technical field of organic micromolecular fluorescent probe analysis and detection; adding 4-bromomethyl phenylboronic acid pinacol ester and introducing N 2 Reflux reaction; after the reaction is completed, the mixture is cooled to room temperature, and the solid is separated out by recrystallization and purified to obtain the target product. The probe has excellent photophysical property, good biocompatibility and inherent mitochondrial targeting capability, and can realize the targeting of mitochondrial H 2 O 2 Is selected from the group consisting of a plurality of detection probes. The synthesis raw material cost of the probe is low, the synthesis route is simple, the reaction condition is mild, the treatment is simple, the yield is high, the fluorescence background of the probe is low in sensitivity and low in detection limit, and the probe is matched with H 2 O 2 After the reaction, the obvious fluorescence of Turn on is realized, so that the interference of autofluorescence of biological tissues is avoided, and the method is suitable for mitochondria H in biological tissue samples 2 O 2 And (3) detecting the level.
Description
Technical Field
The invention belongs to the technical field of organic micromolecular fluorescent probe analysis and detection, and particularly relates to a fluorescent probe for detecting mitochondrial hydrogen peroxide, and a preparation method and application thereof.
Background
Mitochondria are organelles with semi-autonomy in eukaryotic cells, and are short rods or spheres, generally about 0.5-1.0 μm in diameter. Mitochondria produce Adenosine Triphosphate (ATP) through the aerobic respiration process, providing energy for the vital activity. Reactive Oxygen Species (ROS) are unavoidable byproducts of mitochondrial oxidative phosphorylation, and more than 80% of ROS in the cell are derived from mitochondria under physiological conditions. ROS include superoxide anions (O) 2 -hydroxyl radical (OH), hydrogen peroxide (H) 2 O 2 ) Etc. in various forms, wherein H 2 O 2 The most important active oxygen in the cell has the characteristics of low oxidation-reduction potential (weak reactivity), long half-life period (stable), small molecular polarity (capable of penetrating biological membranes), long diffusion distance and the like, and has the dual functions of causing cell damage and intracellular messengers. At sub-toxic concentrations, it will modulate the functional state of its target in a reversible binding or modification manner, acting by affecting the activity of a variety of signaling pathway proteins. In eukaryotic cells, H 2 O 2 The concentration is tightly controlled. During evolution, the organism divides H by compartmentalization against the oxidase system 2 O 2 Is limited to a specific subcellular range, while mitochondria are the only ones with intact H 2 O 2 Organelles of the production/removal system. Thus, mitochondrial H 2 O 2 The change in concentration is a key signal that it modulates specific target molecules, affecting the biological behavior of cells. However, due to technical limitations and complexity of the biological environment, mitochondrial H is currently not available in living cells or in vivo 2 O 2 And (3) accurately detecting the level.
In recent years, H in living body 2 O 2 The detection method of the level comprises electrochemical analysis, chemiluminescence, spectrophotometry, enzyme-linked immunosorbent assay, mass spectrum and the like. However, these methods require complex sample preparation, are time consuming and expensive, and destroy cell/tissue structures, and cannot meet the requirements of real-time non-invasive detection of living cells or living bodies. Fluorescent probe technology has sensitivityThe small molecular dye can realize target molecular marking on molecular, cell and living body levels, and is widely applied to real-time detection and imaging of a life system. Since the organism contains autofluorescent molecules (such as reduced Nicotinamide Adenine Dinucleotide (NADH), folic acid, etc.), background signals are generated to interfere with detection of target molecules, and H 2 O 2 Can freely diffuse in/between cells, and causes generation of pseudo signals outside mitochondria, so that development of a mitochondrial H with low background and high specificity is highly demanded 2 O 2 Visual detection tool for realizing mitochondrial H 2 O 2 Efficient, specific and spatiotemporal dynamic detection of mitochondrial H from multiple levels of molecules, cells and individuals 2 O 2 Signal conditioning and mechanism of (a) are provided.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention aims to provide a fluorescent probe for detecting mitochondrial hydrogen peroxide, a preparation method and application thereof, and designs a targeted mitochondrial H through a intramolecular twist charge transfer (TICT) mechanism 2 O 2 Low background, specific fluorescent probes. The probe has low fluorescence background and high sensitivity, and is matched with H 2 O 2 After the reaction, significant fluorescence "turnon" is achieved, thereby avoiding interference of autofluorescence of biological tissues.
In order to achieve the above purpose, the invention is realized by adopting the following technical scheme:
the invention provides a fluorescent probe for detecting mitochondrial hydrogen peroxide, which has the structural formula:
the invention provides a preparation method of a fluorescent probe for detecting mitochondrial hydrogen peroxide, which comprises the following steps:
s1: adding dye and acetonitrile, heating to a preset temperature, and stirring until the dye and the acetonitrile are completely dissolved;
s2: adding 4-bromomethyl phenylboronic acid pinacol ester and introducing N 2 Reflux reaction;
s3: after the reaction is completed, standing and cooling to room temperature, recrystallizing to separate out solid, and purifying to obtain a target product;
when the dye isWhen the target product is
When the dye isWhen the target product is
When the dye isWhen the target product is
The invention further provides that in S1, the preparation process is carried out in a 50mL Schlenk reaction bottle; the dosage of the acetonitrile is 5ml; the preset temperature is 50 ℃; in the step S2, the reaction time is 12h.
In the invention, in the step S3, the reaction is completely confirmed by adopting TLC (thin layer chromatography) plate tracking; the purification process is to carry out suction filtration washing by adopting EA.
The invention provides a dye of a fluorescent probe for detecting mitochondrial hydrogen peroxide, which has the following structure:
the invention provides a preparation method of a fluorescent probe dye for detecting mitochondrial hydrogen peroxide, which comprises the following steps:
s01: dissolving t-BuOK with anhydrous DMF under stirring, dissolving in N 2 Slowly injecting picoline under the atmosphere, and stirring the solution from colorless to brownish black;
s02: injecting na-CHO DMF solution, stirring at a certain temperature and reacting for a certain time;
s03: cooling to room temperature after the reaction is finished, adding distilled water, extracting by EA until an organic phase is colorless, washing, drying, removing a solvent, and purifying a crude product by column chromatography to obtain a target product;
when the picoline is 4-picoline, the target product is
Or (b)
When the picoline is 3-picoline, the target product is
Or (b)
When the picoline is 2-picoline, the target product is
In the invention, in the step S01, the stirring temperature is 40 ℃, and the stirring time is 1h.
In the step S02, TLC is adopted to monitor the reaction progress in the reaction process; the certain temperature is 50 ℃, and the certain time is 4 hours.
In the step S03, washing is performed by adopting potassium hydroxide solution; the drying is carried out by adopting anhydrous sodium sulfate; the chromatographic purification adopts petroleum ether and ethyl acetate for chromatographic purification; the volume ratio of petroleum ether to ethyl acetate is 2:1.
The fluorescent probe for detecting mitochondrial hydrogen peroxide is adopted to detect mitochondrial H in living cells 2 O 2 The specific detection and fluorescence microscopic imaging analysis.
Compared with the prior art, the invention has the following beneficial effects:
the invention provides a fluorescent probe for detecting mitochondrial hydrogen peroxide, which has excellent photophysical properties and is used for detecting mitochondrial H 2 O 2 The detection of the method has the characteristics of good selectivity, high sensitivity, low detection limit and the like; the synthesis raw material of the probe has low cost, simple synthesis route, mild reaction condition, simple treatment and higher yield, and has the advantage of commercialization; the probe synthesized by the invention has good biocompatibility and inherent mitochondrial targeting capability, so that the probe is suitable for living cell mitochondrial H 2 O 2 Specific detection and fluorescence microscopic imaging analysis of (2); the probe has low fluorescence background and high sensitivity, and is matched with H 2 O 2 After reaction, the obvious fluorescence 'Turn on' is realized, so that the interference of autofluorescence of biological tissues is avoided, and the method can be used for mitochondrial level H of living bodies and clinical serum samples 2 O 2 The detection has commercial development application value.
Drawings
FIG. 1, panels (a-d) are HPLC-MS monitoring probes and H 2 O 2 A process of gradually converting the dye after the reaction;
FIG. 2, panels (A-B), shows probe and dye absorption/emission spectroscopy tests;
FIG. 3 shows graphs (A-F) of probes Mito-W1 and H 2 O 2 Testing responsiveness;
FIG. 4 shows graphs (A-F) of probes Mito-W2 and H 2 O 2 Testing responsiveness;
FIG. 5 (A-F) shows probes Mito-W3 and H 2 O 2 ResponsivenessTesting;
FIG. 6, panels (A-B), shows probe biocompatibility and zeta potential tests;
FIG. 7 (A-C) shows the probe Mito-W2 for 0-10. Mu.M exogenous H in four different cell lines HepG2, SH-SY5Y, U87 and HUVED 2 O 2 Imaging, detection applications of (a);
FIG. 8 is a diagram (A-F) of endogenous H of probe Mito-W2 in both HepG2 and SH-SY5Y cells 2 O 2 Imaging, detection applications of (a);
FIG. 9 (A-F) shows the use of probe Mito-W2 in animal and clinical serum samples;
FIG. 10 shows the synthesis route of dye (pre-Mito-1/2/3);
FIG. 11, panels (A-C), shows the synthetic route of the probe (Mito-W1/W2/W3).
Detailed Description
The invention provides a fluorescent probe for detecting mitochondrial hydrogen peroxide, a preparation method and application thereof. A preparation method of a fluorescent probe for detecting mitochondrial hydrogen peroxide comprises the following steps:
s1: adding dye and acetonitrile, heating to a preset temperature, and stirring until the dye and the acetonitrile are completely dissolved;
s2: adding 4-bromomethyl phenylboronic acid pinacol ester and introducing N 2 Reflux reaction;
s3: after the reaction is completed, standing and cooling to room temperature, recrystallizing to separate out solid, and purifying to obtain a target product; when the dye isWhen the target product is->
When the dye isWhen the target product is
When the dye isWhen the target product is
A preparation method of a fluorescent probe dye for detecting mitochondrial hydrogen peroxide comprises the following steps:
s01: dissolving t-BuOK with anhydrous DMF under stirring, dissolving in N 2 Slowly injecting picoline under the atmosphere, and changing the stirring solution from colorless to brown-black;
s02: injecting na-CHO DMF solution, stirring at a certain temperature and reacting for a certain time;
s03: cooling to room temperature after the reaction is finished, adding distilled water, extracting by EA until an organic phase is colorless, washing, drying, removing a solvent, and purifying a crude product by column chromatography to obtain a target product;
when the picoline is 4-picoline, the target product is
When the picoline is 3-picoline, the target product is
When the picoline is 2-picoline, the target product is
The invention will be further illustrated with reference to specific examples. It is to be understood that these examples are illustrative of the present invention and are not intended to limit the scope of the present invention. Further, it is understood that various changes and modifications may be made by those skilled in the art after reading the teachings of the present invention, and such equivalents are intended to fall within the scope of the claims appended hereto.
1. Dye (pre-Mito-1/2/3) synthetic route
Example 1
Synthesis of dye pre-Mito-1: in a 50mL two-necked flask, t-BuOK (437 mg,3.9 mmol) and 10mL anhydrous DMF were added and dissolved with stirring. At N 2 4-methylpyridine (284 mg,5.2 mmol) was slowly injected under an atmosphere, stirred at 40℃for 1h, the solution turned from colorless to brownish black, then na-CHO (595 g,2.6 mmol) in DMF was injected and stirred at 50℃for 4h, and the progress of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was cooled to room temperature, 100mL of distilled water was added, the organic phase was extracted to colorless with EA, and the organic phase was washed with a potassium hydroxide (1M) solution for 1 time and dried over anhydrous sodium sulfate. The solvent was removed and the crude product was purified by column chromatography (PE/ea=1/2) to give the yellow solid product pre-Mito-1 (514 mg, 65%).
1 H NMR(500MHz,DMSO-d 6 )δ(ppm):8.53(d,J=4.5Hz,2H),7.87(d,J=12.0Hz,1H),7.79–7.50(m,6H),7.22(d,2H),6.92(s,1H),4.73(d,J=4.5Hz,1H),3.58(dd,J=38.6,5.4Hz,4H),3.06(s,3H). 13 C NMR(125MHz,DMSO-d 6 )δ(ppm):150.44,148.30,145.21,135.58,134.07,129.65,129.47,128.09,126.84,126.06,124.27,124.08,121.06,116.65,105.33,58.81,54.70,40.51.HR-MS(ESI):calcd.for[C 20 H 20 N 2 O]m/z 304.1576,found[M+H] + 305.1633.
Synthesis route of probe (Mito-W1)
Synthesis of probe Mito-W1: in a 50mL Schlenk flask were added pre-Mito-1 (24 mg,0.08 mmol) and 5mL acetonitrile was heated to 50deg.C and stirred until completely dissolved, and 4-bromomethylphenylboronic acid pinacol ester (28 mg,0.096 mmol) was added thereto, followed by N-pass 2 The reaction was refluxed for 12h and the TLC plate was followed until the starting material was completely reacted. And (3) standing and cooling to room temperature, recrystallizing to precipitate a solid, and purifying, namely, carrying out suction filtration and washing by adopting EA to obtain a black-red crystalline product Mito-W1 (46 mg, 96%).
1 H NMR(500MHz,DMSO-d 6 )δ(ppm):8.98(d,J=6.8Hz,2H),8.21(d,J=6.8Hz,2H),8.11(d,J=16.1Hz,1H),7.99(s,1H),7.75(ddd,J=34.3,17.7,7.0Hz,5H),7.54–7.45(m,3H),7.26(dd,J=9.2,2.4Hz,1H),6.95(d,J=2.1Hz,1H),5.76(s,2H),4.75(t,J=5.3Hz,1H),3.67–3.52(m,4H),3.09(s,3H),1.29(s,12H). 13 C NMR(125MHz,DMSO-d 6 )δ(ppm):154.28,149.21,144.54,142.90,138.24,136.71,135.64,131.00,130.20,128.45,127.14,125.69,124.40,123.96,120.92,116.80,105.27,84.36,62.39,58.81,54.55,40.51,25.10.HR-MS(ESI):calcd.for[C 33 H 38 BN 2 O 3 + ]m/z 521.2970,found[M] + 521.2996.
Example 2
Synthesis of dye pre-Mito-2: similar to the pre-Mito-1 synthesis, except for the difference in starting material (3-methylpyridine), the product pre-Mito-2 (399mg, 50%) was obtained as a yellow solid.
1 H NMR(500MHz,DMSO-d 6 )δ(ppm):8.78(s,1H),8.44(s,1H),8.05(d,J=6.7Hz,1H),7.82(s,1H),7.75–7.62(m,3H),7.49–7.36(m,2H),7.24(dd,J=24.8,12.6Hz,2H),6.91(s,1H),4.72(s,1H),3.57(d,J=40.3Hz,4H),3.06(s,3H). 13 C NMR(125MHz,DMSO-d 6 )δ(ppm):148.54,148.41,148.09,135.26,133.72,132.79,131.48,130.22,129.30,127.24,126.78,126.16,124.24,124.16,123.15,116.64,105.38,58.81,54.74,40.59.HR-MS(ESI):calcd.for[C 20 H 20 N 2 O]m/z 304.1576,found[M+H] + 305.1629.
Synthetic route to the probe (Mito-W2):
synthesis of probe Mito-W2: similar to the Mito-W1 synthesis, except for the difference in starting material (pre-Mito-2), an orange-colored crystalline product Mito-W2 (41 mg, 86%) was obtained.
1 H NMR(500MHz,DMSO-d 6 )δ(ppm):9.38(s,1H),8.96(d,J=6.0Hz,1H),8.79(d,J=8.2Hz,1H),8.14(dd,J=8.2,6.0Hz,1H),7.85(s,1H),7.83–7.65(m,6H),7.56(d,J=8.1Hz,2H),7.36(d,J=16.4Hz,1H),7.23(dd,J=9.2,2.5Hz,1H),6.91(d,J=2.2Hz,1H),5.86(s,2H),4.72(t,J=5.3Hz,1H),3.59(t,J=5.6Hz,2H),3.53(t,J=5.9Hz,2H),3.05(s,3H),1.28(s,12H). 13 C NMR(125MHz,DMSO-d 6 )δ(ppm):148.63,142.62,142.34,141.53,139.05,137.73,136.84,135.95,135.65,129.71,128.95,128.85,128.70,127.07,125.89,123.98,119.27,116.77,105.29,84.38,63.91,58.79,54.63,40.60,25.10.HR-MS(ESI):calcd.for[C 33 H 38 BN 2 O 3 + ]m/z 521.2970,found[M] + 521.2917.
Example 3
Synthesis of dye pre-Mito-3: similar to the pre-Mito-1 synthesis, except for the difference in starting material (2-methylpyridine), the product pre-Mito-3 (356 mg, 45%) was obtained as a yellow solid.
1 H NMR(500MHz,DMSO-d 6 )δ(ppm):8.57(d,J=3.8Hz,1H),7.86(s,1H),7.81–7.71(m,4H),7.65(d,J=8.6Hz,1H),7.53(d,J=7.9Hz,1H),7.29(d,J=16.0Hz,1H),7.26–7.20(m,2H),6.91(d,J=2.3Hz,1H),4.72(t,J=5.3Hz,1H),3.67–3.49(m,4H),3.06(s,3H). 13 C NMR(125MHz,DMSO-d 6 )δ(ppm):155.93,149.93,148.17,137.21,135.43,133.11,129.89,129.40,127.88,126.80,126.36,126.18,124.40,122.52,122.36,116.59,105.36,58.81,54.73,40.60.HR-MS(ESI):calcd.for[C 20 H 20 N 2 O]m/z 304.1576,found[M+H] + 305.1625.
Synthesis route of probe (Mito-W3)
Synthesis of probe Mito-W3: similar to the Mito-W1 synthesis procedure, except for the difference in starting material (pre-Mito-3), a dark red crystalline product Mito-W3 (38 mg, 81%) was obtained.
1 H NMR(500MHz,DMSO-d 6 )δ(ppm):9.06(d,J=6.2Hz,1H),8.63–8.49(m,3H),7.96(dd,J=20.9,11.4Hz,3H),7.75(d,J=9.2Hz,2H),7.68(dd,J=8.4,4.4Hz,2H),7.52(d,J=15.7Hz,1H),7.35(d,J=7.9Hz,2H),7.25(dd,J=9.2,2.4Hz,1H),6.93(d,J=2.1Hz,1H),6.15(s,2H),4.74(t,J=5.3Hz,1H),3.67–3.49(m,4H),3.08(s,3H),1.23(s,12H). 13 C NMR(125MHz,DMSO-d 6 )δ(ppm):153.16,149.32,146.28,145.06,144.69,138.02,136.82,135.54,131.57,130.28,128.17,127.29,127.12,125.72,125.53,125.14,124.39,116.82,114.64,105.25,84.31,60.43,58.80,54.55,40.60,25.09.HR-MS(ESI):calcd.for[C 33 H 38 BN 2 O 3 + ]m/z 521.2970,found[M] + 521.2922.
HPLC-MS test method and conditions
HPLC-MS mobile phase is methanol-water (0.1% HCOOH), flow rate 1mL/min (gradient setup: equilibration time 3min 40% CH 3 OH/60%H 2 O;0-5min:40%CH 3 OH/60%H 2 O-50%CH 3 OH/50%H 2 O;5-10min:50%CH 3 OH/50%H 2 O-70%CH 3 OH/30%H 2 O;10-15min:70%CH 3 OH/30%H 2 O-90%CH 3 OH/10%H 2 O;15-20min:90%CH 3 OH/10%H 2 O-100%CH 3 OH/0%H 2 O), uv detector (wavelength 254 nm) distinguishes chromatographic peaks, mass spectrum detector (ISQ-EC) recognizes molecular weights of different components. The probes Mito-W1/Mito-W2/Mito-W3 (50. Mu.M) in CH 3 OH (80%) and H 2 O (20%) mixed solution is respectively mixed with H 2 O 2 (5 mM) HPLC-MS test was performed after various times of reaction at 37 ℃. Intermediate captured by MS to speculate that the pinacol ester of phenylboronic acid compound was reacted with H 2 O oxidation reaction mechanism.
3. Absorption/emission spectrum test method and conditions
A certain amount of dye (pre-Mito-1/pre-Mito-2/pre-Mito-3) and probe (Mito-W1/Mito-W2/Mito-W3) solids were accurately weighed and prepared into a mother solution with a concentration of 1mM by using biological-grade DMSO. The solvent used for the spectroscopic test was PBS buffer (ph=7.42, 10mM,0.02%Triton X-100) with a sample concentration of 10 μm.
3.1 calculation of relative fluorescence Quantum yield
Using the reference method, the fluorescence quantum yield of the dye was based on fluorescein as reference substance (Φ in 0.1M NaOH solution r =0.92), the fluorescence quantum yield of the probe was referenced to rhodamine B (Φ in absolute ethanol r =0.89). The relative fluorescence quantum yields of the dye and probe in PBS buffer (ph=7.42, 10mM,0.02%Triton X-100) were calculated according to formula (1), respectively.
Wherein, the phi fluorescence quantum yield, A is absorbance, F is fluorescence integration area, and n is refractive index of the solution. r and s represent the standard substance and the substance to be measured, respectively.
3.2 reaction kinetic constant test
1. Mu.M probe (Mito-W1/Mito-W2/Mito-W3) was incubated with 10mM H in PBS buffer (pH=7.42, 10mM,0.02%Triton X-100), respectively 2 O 2 Mixing well, and recording fluorescence emission spectrum (lambda) at 400-650nm with fluorescence spectrometer ex =359 nm/358nm/378 nm), the relationship between the time and the fluorescence intensity was calculated and linear fitting was performed, and the first order reaction kinetic constant K was measured according to formula (2).
Wherein F is final As the final fluorescence intensity value, F t The fluorescence intensity values at different time points are shown, and t is time.
3.3 detection Limit test
10. Mu.M probe @ in PBS (pH=7.42, 10mM,0.02%Triton X-100) -acetone (V: V=1:1) solutionMito-W1/Mito-W2/Mito-W3) is added with 0-10eq of H respectively 2 O 2 (0-100. Mu.M), after incubation at 37℃for 2h, spectroscopic testing (lambda.) was performed using a fluorescence spectrometer ex =359 nm/358nm/378 nm), calculate H 2 O 2 The relationship between the concentration (0-100. Mu.M) and the fluorescence intensity of the probe (10. Mu.M) was subjected to linear fitting, and the detection limit LOD was measured according to the formula (2).
Where σ is the standard deviation of 11 blank samples tested, k is H 2 O 2 Slope of the linear relationship of concentration and fluorescence intensity.
3.4 anti-tamper test
The preparation of 10mM interference factor stock solution comprises: f1. F - ;2.Cl - ;3.Br - ;4.I - ;5.NO 3 - ;6.HS - ;7.SCN - ;8.HSO 3 - ;9.H 2 PO 4 - ;10.HCO 3 - ;11.SO 4 2- ;12.S 2 - ;13.CO 3 2- ;14.HPO 4 2- ;15.Na + ;16.K + ;17.Mg 2+ ;18.Zn 2+ ;19.Cu 2+ ;20.Fe 2+ ;21.Mn 2+ ;22.Ba 2+ ;23.Ni 2+ ;24.Ca 2+ ;25.Cd 2+ ;26.Fe 3+ ;27.Al 3+ ;28.Cr 3+ ;29.Gly;30.Ala;31.Val;32.Ile;33.Phe;34.Trp;35.Met;36.Pro;37.Ser;38.Thr;39.Cys;40.Tyr;41.His;42.Lys;43.Arg;44.Asp;45.Glu;46.H 2 O 2 ;47.·OH;48.ONOO - ;49.ROO·.50. 1 O 2 ;51.ClO - . 10. Mu.M probe and 100. Mu.M different interference factors were added to PBS buffer (pH=7.42, 10mM,0.02%Triton X-100), and after incubation at 37℃for 2h, fluorescence intensities of the probe at the dual excitation wavelengths (probe optimal absorption wavelength and dye optimal absorption wavelength) were recorded using a fluorescence spectrometer, respectively.
4. Biocompatibility Log P test
Octanol-water partition coefficient (log P) is a membrane permeability in vitro simulated test of a compound. In a 5mL EP tube, n-octanol (2 mL) and water (2 mL) were added, along with a 10. Mu.M sample, the mixture was centrifuged at 5000rpm for 3min after vortexing, the n-octanol layer was separated from the water layer, and the absorbance of the two phases was measured using UV-visible absorption spectroscopy. The Log P value is measured according to equation (4).
Wherein A is o And A w Absorbance of the sample in n-octanol and water phase, respectively.
5. Cell experiment
5.1 cell culture
Human HepG2 (hepatoma cell) and SH-SY5Y (neuroblastoma cell), U87 (glioma cell), HUVED (umbilical vein endothelial cell) cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% Fetal Bovine Serum (FBS), 1% streptomycin and penicillin at 37℃under 5% CO 2 Is a cell culture box.
5.2 cell imaging experiments
Cells were inoculated in confocal dishes, confluence was 60% after adherence overnight, phenol red-free serum-free medium containing Mito-W2 and Mitotracker Deep Red at 1 μΜ was added, incubated with cells for 30min, washed 2 times with PBS, and laser confocal imaging was performed in phenol red-free serum-free medium. Imaging conditions: mito-W2 excitation light lambda ex Emission light λ=405 nm em Receiving wave band: 450-550nm; mitotracker Deep Red excitation λex=650 nm, emission λem reception band: 600-700nm.
5.3 flow cytometer detection
Cells were seeded in 6-well plates, incubated with phenol red-free serum-free medium cells containing 1 μm Mito-W2 and Mitotracker Deep Red for 30min, collected by digestion centrifugation (n=3), washed one to two times with PBS, detected by flow cytometry, excitation wavelength 405nm, detection wavelength 525nm.
5.4 Amplex Red detection
Cell mitochondria were isolated by differential centrifugation and mitochondrial H was detected by fluorescence according to the kit protocol (Invitrogen A22188) 2 O 2 Is a level of (c).
6. Animal experiment
Adult male C57 mice were selected from the experimental animals. In the first part, 200 mu L Mito-W2 with the concentration of 2 mu M/L is injected into tail vein after different time points (1 d/3d/5 d) after 70% partial hepatectomy, the liver is extracted after 2h injection, and a small animal living body imager is used for organ imaging, and a control group is a sham operation group; the second part, based on mCAT adeno-associated virus treated mice, was subjected to 70% hepatectomy, and after 1d tail vein injection Mito-W2, and after 2h, liver was extracted for organ imaging. Meanwhile, H in isolated mitochondria of liver tissue was detected using a commercial Amplex Red hydrogen peroxide detection kit (Invitrogen A22188) 2 O 2 Horizontal.
7. Clinical serum sample experiment
Serum samples were from Tang Dou hospital, beijing power release army Hospital, beijing rocket army Hospital. The disease group is myocardial infarction patient (Stroke) or Parkinson's Disease (PD), and the normal control group is selected from healthy people matched with the age range of the disease group. Firstly, adding an equal volume of acetone into serum, uniformly mixing, centrifuging at 12000rcf/min for 10min at 4 ℃, extracting supernatant and preserving at 0 ℃. The purpose is as follows: proteins in serum are removed, and autofluorescence of the proteins is avoided to interfere with detection results. Mito-W2 (1. Mu.M) was then added to the supernatant, and immediately fluorescence test (fluorescence intensity: F1) was performed, and after incubation for 3 hours, fluorescence test (fluorescence intensity: F2) was performed again. Finally, the change in fluorescence intensity before and after the reaction (F2-F1) was subjected to statistical analysis (t-test).
The invention provides a fluorescent probe for detecting mitochondrial hydrogen peroxide, which is designed to target mitochondrial H 2 O 2 Low background, specific fluorescent probes. The design of the fluorescent probe is based on an intramolecular distorted charge transfer (tic) mechanism. Wherein the electron donating group (Donor, D) is naphthylamine, and hydroxyethyl is introduced on amino nitrogen atom to increase molecular water solubilityThe method comprises the steps of carrying out a first treatment on the surface of the The electron withdrawing group (A) moiety contains a group which can be substituted with H 2 O 2 Specifically oxidizing the pyridinium salt of the identified pinacol ester of p-methylphenylboronic acid; the D and A parts are connected through pi bridge to construct D-pi-A type molecule, thus facilitating electron delocalization and increasing charge transmission performance. The overall intrinsic positive charge of the probe molecule effectively targets mitochondria (mitochondrial membrane potential-180 mV) by electrostatic attraction. Experimental results show that, with H 2 O 2 Prior to reaction, the probe Mito-W2 was extremely low in Brightness (Brightness (Mito-W2) =15), and H 2 O 2 After the reaction, the dye was converted to a dye pre-Mito-2 Brightness (Brightness (pre-Mito-2) =2555), is 1113 times the pre-reaction probe fluorescence intensity, achieving significant fluorescence "Turn-on". The selective test result shows that the probe pair H 2 O 2 Can specifically recognize and is not interfered by other molecules, and the detection Limit (LOD) is as low as 14.05nM. The above results indicate that Mito-W2 can be used as a low background specificity detection for mitochondrial H 2 O 2 Is provided.
In addition, we have systematically studied the pyridinium salts H at different pyridinium nitrogen positions (para/meta/ortho) linked to pi bonds 2 O 2 The photophysical properties of the probe (Mito-W1/Mito-W2/Mito-W3) verify that the probe Mito-W2 designed according to the invention has a low background for detecting mitochondrial H 2 O 2 Is a characteristic of (a). The invention provides two other (para and ortho) different pyridinium salts H 2 O 2 The probes (Mito-W1 and Mito-W3) were compared in nature and the three probe structures were as follows:
1. first, as shown in the diagrams (a-d) of FIG. 1, a probe (Mito-W1/W2/W3) was combined with H by high performance liquid chromatography-mass spectrometry (HPLC-MS) 2 O 2 The position of the chromatographic peak after the reaction and the molecular weight of the corresponding component are qualitatively characterized by the gradual conversion of the monitoring probe from the intermediate to the dye (pre-Mito-1/2/3).
2. Next, as shown in the graph (A-B) of FIG. 2,the photophysical properties of the three probes and dyes in PBS buffer (ph=7.42, 10mM,0.02%Triton X-100) were studied by an ultraviolet-visible spectrophotometer (UV-Vis spectrophotometer) and fluorescence spectrometer (Fluorescence spectrophotometer) system, including optimal absorption emission wavelength, stokes shift, relative fluorescence quantum yield, molar extinction coefficient, brightness (as shown in table 1). The optimal absorption/emission wavelengths of the probe Mito-W1 and the dye pre-Mito-1 are 470/647nm,359/521nm, respectively, and the Brightness (Brightness) is 514 and 543; the optimal absorption/emission wavelengths of Mito-W2 and pre-Mito-2 are 395/600nm,358/493nm and Brightness of 15 and 2555 respectively; the optimal absorption/emission wavelengths for Mito-W3 and pre-Mito-3 are 477/625nm,378/502nm, respectively, and Brightness is 402 and 2476. Indicating probe and H 2 O 2 After the reaction, the dye is converted into a dye with high brightness, and fluorescence of Turn-on is realized.
Table 1 shows the basic photophysical data of the dyes and probes.
3. Next, probe pair H was evaluated by fluorescence spectroscopy testing 2 O 2 Is a response (sensitivity and selectivity) capability of (a) a target. As shown in FIG. 3, panels (A-F), H was added to probe Mito-W1 (1. Mu.M) at 359nm as excitation wavelength 2 O 2 After (1 mM), the fluorescence intensity of the probe was significantly increased with time, and the reaction was completed at 110min, and the apparent rate constant K of the first order reaction was measured obs (Mito-W1)=0.0118min -1 The method comprises the steps of carrying out a first treatment on the surface of the Mito-W1 (10. Mu.M) was added with different concentrations of H 2 O 2 Then, 359nm is used as excitation wavelength, and the fluorescence intensity of the probe is along with H 2 O 2 The concentration is increased and enhanced, and the linear relation is better in the range of 0-40 mu M, so that the detection limit LOD (Mito-W1) =53.15 nM is calculated; mito-W1 (10. Mu.M) and common anions and cations, amino acids and ROS (100. Mu.M) in organisms were incubated at 37deg.C for 2H, respectively, with 470/359nm as excitation wavelength, fluorescence test showed that H was removed 2 O 2 In addition, mito-W1 has no fluorescence intensity in the presence of other biomoleculesObvious change, indicating that the probe is H 2 O 2 Specific response, fluorescence was 93-fold enhanced.
As shown in FIG. 4, panels (A-F), probe Mito-W2 (1. Mu.M) was excited at 358nm, and H was added 2 O 2 After (1 mM), the fluorescence intensity of the probe was significantly increased with time, and the reaction was completed at 110min, and the apparent rate constant K of the first order reaction was measured obs (Mito-W2)=0.0151min -1 The method comprises the steps of carrying out a first treatment on the surface of the Mito-W2 (10. Mu.M) was added at various concentrations of H 2 O 2 Then, the detection limit LOD (Mito-W2) =14.05 nm is calculated with a better linear relation in the range of 0-100 mu M; different biomolecular experiments showed Mito-W2 (10. Mu.M) vs. H 2 O 2 Specific response, fluorescence was significantly enhanced 1113-fold, achieving significant fluorescence "turnon".
As shown in FIG. 5, panels (A-F), probe Mito-W3 (1. Mu.M) was excited at 378nm, and H was added 2 O 2 After (1 mM), the fluorescence intensity of the probe was significantly enhanced with time, and the reaction was completed at 70min, and the apparent rate constant K of the first order reaction was measured obs (Mito-W3)=0.0476min -1 The method comprises the steps of carrying out a first treatment on the surface of the Mito-W3 (10. Mu.M) was added at various concentrations of H 2 O 2 (0-100 μm), has a good linear relationship, and the detection limit LOD (Mito-W3) =44.79 nm; different biomolecular experiments showed Mito-W3 (10. Mu.M) vs. H 2 O 2 The specific response fluorescence was increased 407-fold.
4. The biological properties of the probes and dyes were further studied by oil/water separation coefficient (Log P) and Zeta potential tests. As shown in figure 6, panel a, the probe and dye (Log P < 0.7) have good lipophilic/oleophilic properties, and as shown in figure 6, panel B, zeta potential characterization results demonstrate that the probe is positively charged (> 10 mV) in aqueous solution, enabling targeting of mitochondria with negative membrane potential by electrostatic adsorption.
As a result of comparison of the above experimental results, mito-W2 is a P H 2 O 2 The probe with high selectivity and high sensitivity response has lower fluorescence before detection, and the fluorescence intensity after detection is obviously enhanced, and can be used as a low background H 2 O 2 Fluorescent probes were used in biological studies, thus also validating our original setupAnd (5) counting.
5. Laser confocal fluorescence imaging (Confocol), flow cytometry and commercial kit research probe Mito-W2 for mitochondrial H in cell and animal models 2 O 2 Horizontal detectability.
Exogenous H 2 O 2 And (3) detection:
as shown in FIG. 7, panel A, different concentrations of H were added to each of the four different types of cells HepG2, SH-SY5Y, U, HUVED, respectively 2 O 2 Confocal fluorescence imaging was performed after (0-10. Mu.M) co-incubation with Mito-W2 (1. Mu.M) and commercial dye Mitotracker Deep Red (1. Mu.M). With H 2 O 2 The increase of the dosage, the fluorescence signal of the cells is gradually enhanced and better in co-localization with Mitotracker Deep Red, and the mitochondrial targeting ability of Mito-W2 in the cells is verified. Mito-W2 (1. Mu.M) labelled cells were then detected by flow cytometry at different concentrations of H 2 O 2 (0-10. Mu.M) change in fluorescence intensity after treatment, consistent with confocal imaging results, as shown in FIG. 7, panel B. Finally, mitochondria in cells were extracted, and fluorescence intensity in mitochondria was detected with a commercial kit (duplex red kit), consistent with Mito-W2 confocal imaging and flow cytometry detection results, as shown in FIG. 7, panel C. The results in summary show that: mito-W2 has good compliance and high sensitivity in common fluorescent signal detection platforms such as microscopic imaging and flow.
Endogenous H 2 O 2 And (3) detection:
(1) Directly or indirectly regulating and controlling endogenous H of HepG2 and SH-SY5Y cells through gene editing means 2 O 2 Horizontal. First at 10 mu M H 2 O 2 The cells are transfected by using a viral vector on the basis of the treated cells to enable the cells to specifically overexpress mitochondrial catalase mCAT (control), thereby directly reducing H in mitochondria 2 O 2 After incubation with Mito-W2 for 30min, the fluorescence signal was detected by confocal microscopy (Mitotracker Deep Red co-localization) and flow cytometry. Addition of exogenous H to HepG2 control cells 2 O 2 Post fluorescence is significantly enhanced, while H 2 O 2 Treatment of mCAT expressing cellsNo significant enhancement of the fluorescence signal was seen, as shown in fig. 8, panel a. In the case where the processing conditions were unchanged, the flow cytometer (shown in fig. 8, panel B) and the kit detection result (shown in fig. 8, panel C) were consistent with the confocal. SH-SY5Y cells were similar to HepG2 cells in experimental results. The results show that: intracellular mCAT overexpression can significantly inhibit exogenous H 2 O 2 Mito-W2 specifically detectable mCAT overexpression induced mitochondrial H 2 O 2 And (3) lowering.
(2) Monoamine oxidase (MAO) of different subtypes is overexpressed by HepG2 and SH-SY5Y, respectively (MAO-B is overexpressed by HepG2, MAO-A is overexpressed by SH-SY 5Y), thereby causing mitochondrial H 2 O 2 The elevated levels were followed by mitochondrial antioxidant Mito Q treatment (control) and then incubation with Mito-W2 for 30min, after which fluorescence signals were detected using confocal microscopy (Mitotracker Deep Red co-localization) and flow cytometry. Confocal imaging results show that: mito-W2 showed a significant increase in fluorescence signal in MAO-overexpressing cells, whereas after Mito Q treatment, the signal was significantly reduced as shown in panel D of FIG. 8. SH-SY5Y cells were consistent with HepG2 cell experiments. The flow cytometer detection results (as shown in fig. 8, panel E) and the kit detection results (as shown in fig. 8, panel F) were consistent with confocal under unchanged processing conditions. The results show that: MAO overexpression can significantly increase endogenous H of cells 2 O 2 At the level, mito Q can effectively remove H 2 O 2 . Mito-W2 specifically detects MAOB over-expression induced mitochondrial H 2 O 2 Elevation and exogenous mitochondrial antioxidant enzyme induced H 2 O 2 And (3) lowering.
Mouse liver resection model:
Mito-W2 sensitively reflects intrahepatic H at various time points of hepatectomy using a 70% post hepatectomy regeneration model in mice as shown in FIG. 9, panel A 2 O 2 Level change of (2); as shown in FIG. 9, panel C, treatment of mice with adeno-associated virus to overexpress mCAT significantly inhibited liver tissue H1 d after hepatectomy 2 O 2 The level, as shown in FIG. 9, panel B or panel D, was consistent with the results of the kit liver tissue homogenate assay. Results tableBright: mito-W2 can realize endogenous H at tissue and organ level 2 O 2 Sensitive detection of changes.
6. Finally, the application performance of the probe Mito-W2 in clinical samples is studied by a fluorescence spectrometry. On the one hand, fluorescence detection was performed after incubation with Mito-W2 (1. Mu.M) added to the serum of the myocardial infarction patient (n=13) and the serum of the normal person of the same age (n=13), and as a result, as shown in FIG. 9, the difference in fluorescence intensity of the myocardial infarction group was significantly higher before and after the change than that of the normal control group (P=0.0058). On the other hand, fluorescence detection was performed after incubation with Mito-W2 (1 μm) added to PD patients (n=26) and normal human serum of the same age (n=26), respectively, and as a result, as shown in fig. 9, panel F showed that the difference in fluorescence intensity before and after PD group was significantly higher than that in the normal control group (P < 0.0001). The results show that: mito-W2 can be used for detecting clinical samples of mitochondrial oxidative stress related diseases.
The probe synthesized by the invention has excellent photophysical property and is suitable for mitochondria H 2 O 2 The detection of the method has the characteristics of good selectivity, high sensitivity, low detection limit and the like; the probe has the advantages of low cost of synthetic raw materials, simple synthetic route, mild reaction conditions, simple treatment, higher yield and commercialization;
the probe synthesized by the invention has good biocompatibility and inherent mitochondrial targeting capability, so that the probe is suitable for living cell mitochondrial H 2 O 2 Specific detection and fluorescence microscopic imaging analysis of (2); the probe has low fluorescence background and high sensitivity, and is matched with H 2 O 2 After reaction, the obvious fluorescence 'Turn on' is realized, so that the interference of autofluorescence of biological tissues is avoided, and the method can be used for mitochondrial level H of living bodies and clinical serum samples 2 O 2 The detection has commercial development application value.
The above is only for illustrating the technical idea of the present invention, and the protection scope of the present invention is not limited by this, and any modification made on the basis of the technical scheme according to the technical idea of the present invention falls within the protection scope of the claims of the present invention.
Claims (7)
1. A method for preparing a fluorescent probe for detecting mitochondrial hydrogen peroxide, which is characterized by comprising the following steps:
s1: adding dye and acetonitrile, heating to a preset temperature, and stirring until the dye and the acetonitrile are completely dissolved;
s2: adding 4-bromomethyl phenylboronic acid pinacol ester and introducing N 2 Reflux reaction;
s3: after the reaction is completed, standing and cooling to room temperature, recrystallizing to separate out solid, and purifying to obtain a target product;
when the dye isWhen the target product is
When the dye isWhen the target product is
When the dye isWhen the target product is
The structural formula of the fluorescent probe is as follows:
the preparation method of the dye is characterized by comprising the following steps:
s01: dissolving t-BuOK with anhydrous DMF under stirring, dissolving in N 2 Slowly injecting picoline under the atmosphere, and stirring the solution from colorless to brownish black;
s02: injecting na-CHO DMF solution, stirring at a certain temperature and reacting for a certain time;
s03: cooling to room temperature after the reaction is finished, adding distilled water, extracting by EA until an organic phase is colorless, washing, drying, removing a solvent, and purifying a crude product by column chromatography to obtain a target product;
when the picoline is 4-picoline, the target product is
Or (b)
When the picoline is 3-picoline, the target product is
Or (b)
When the picoline is 2-picoline, the target product is
The na-CHO has the following structural formula:
2. the method of claim 1, wherein in S1, the preparation process is performed in a 50mL Schlenk flask; the dosage of the acetonitrile is 5ml; the preset temperature is 50 ℃; in the step S2, the reaction time is 12h.
3. The method of claim 1, wherein in S3, the reaction is completely confirmed by TLC plate tracking; the purification process is to carry out suction filtration washing by adopting EA.
4. The method according to claim 1, wherein in S01, the stirring temperature is 40 ℃ and the stirring time is 1h.
5. The method according to claim 1, wherein in S02, TLC is used to monitor the progress of the reaction during the reaction; the certain temperature is 50 ℃, and the certain time is 4 hours.
6. The method according to claim 1, wherein in S03, the washing is performed with a potassium hydroxide solution; the drying is carried out by adopting anhydrous sodium sulfate; the chromatographic purification adopts petroleum ether and ethyl acetate for chromatographic purification; the volume ratio of petroleum ether to ethyl acetate is 2:1.
7. A fluorescent probe prepared by the preparation method of claim 1 for living cell mitochondria H 2 O 2 The application of the detection reagent for the specific detection and fluorescence microscopic imaging analysis is characterized in that the structural formula of the fluorescent probe is as follows:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211034998.8A CN115246854B (en) | 2022-08-26 | 2022-08-26 | Fluorescent probe for detecting mitochondrial hydrogen peroxide and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211034998.8A CN115246854B (en) | 2022-08-26 | 2022-08-26 | Fluorescent probe for detecting mitochondrial hydrogen peroxide and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115246854A CN115246854A (en) | 2022-10-28 |
CN115246854B true CN115246854B (en) | 2024-03-19 |
Family
ID=83699935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211034998.8A Active CN115246854B (en) | 2022-08-26 | 2022-08-26 | Fluorescent probe for detecting mitochondrial hydrogen peroxide and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115246854B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106281310A (en) * | 2016-08-09 | 2017-01-04 | 济南大学 | A kind of Mitochondrially targeted hydrogen peroxide molecule fluorescent probe and its preparation method and application |
-
2022
- 2022-08-26 CN CN202211034998.8A patent/CN115246854B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106281310A (en) * | 2016-08-09 | 2017-01-04 | 济南大学 | A kind of Mitochondrially targeted hydrogen peroxide molecule fluorescent probe and its preparation method and application |
Non-Patent Citations (1)
Title |
---|
Fluororeactands for the Detection of Saccharides Based on Hemicyanine Dyes with a Boronic Acid Receptor;Trupp, Sabine et al.;Microchimica Acta;第153卷;127-131 * |
Also Published As
Publication number | Publication date |
---|---|
CN115246854A (en) | 2022-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | Recent progress in the development of organic dye based near-infrared fluorescence probes for metal ions | |
Yuan et al. | A unique approach to development of near-infrared fluorescent sensors for in vivo imaging | |
Wang et al. | A novel DCM-NBD conjugate fluorescent probe for discrimination of Cys/Hcy from GSH and its bioimaging applications in living cells and animals | |
Muthusamy et al. | A novel lysosome targeted fluorophore for H2S sensing: Enhancing the quantitative detection with successive reaction sites | |
Qi et al. | Recent advances in organic near-infrared ratiometric small-molecule fluorescent probes | |
Feng et al. | A 1, 8-naphthalimide-derived turn-on fluorescent probe for imaging lysosomal nitric oxide in living cells | |
Liu et al. | Lysosome-targeted near-infrared fluorescent dye and its application in designing of probe for sensitive detection of cysteine in living cells | |
CN110698454B (en) | Isophorone hydrogen sulfide fluorescent probe and preparation method and application thereof | |
CN105017196A (en) | Hydrazine near infrared ratio detecting fluorescent probe and application | |
Yang et al. | A novel xanthylene-based effective mitochondria-targeting ratiometric cysteine probe and its bioimaging in living cells | |
Arce et al. | Analysis of the structural and mechanistic factors in antioxidants that preserve mitochondrial function and confer cytoprotection | |
Ni et al. | Convenient construction of fluorescent markers for lipid droplets with 1, 8-naphthalimide unit | |
Chen et al. | Two novel two-photon excited fluorescent pH probes based on the A-π-D-π-A system for intracellular pH mapping | |
CN109928940B (en) | Preparation of near-infrared fluorescent probe molecule for detecting hypochlorous acid based on basic blue-3 | |
Tian et al. | Ratiometric fluorescence imaging for sodium selenite in living cells | |
Sun et al. | Construction of heteroaryl-bridged NIR AIEgens for specific imaging of lipid droplets and its application in photodynamic therapy | |
Wu et al. | Novel near-infrared frequency up-conversion luminescence probe for monitoring biothiols in vitro and in vivo | |
CN109180716B (en) | Multi-signal ratio type distinguishing detection H2O2And H2Design, synthesis and application of fluorescent probe of S | |
He et al. | A water-soluble two-photon fluorescent probe for rapid and reversible monitoring of redox state | |
Yang et al. | A near-infrared fluorescent probe for the discrimination of cysteine in pure aqueous solution and imaging of cysteine in hepatocellular carcinoma cells with facile cell-compatible ability | |
Guan et al. | A quinoline-based indicator for NAD (P) H multimodal detection in vitro and in vivo: Spectrophotometry and visible near-infrared dual-channel lighting-up fluorescence imaging | |
CN115246854B (en) | Fluorescent probe for detecting mitochondrial hydrogen peroxide and preparation method and application thereof | |
Wang et al. | Efficient synthesis and antioxidant activities of N-heterocyclyl substituted Coenzyme Q analogues | |
Zhegalova et al. | Synthesis of nitric oxide probes with fluorescence lifetime sensitivity | |
Resta et al. | Detection of subcellular nitric oxide in mitochondria using a pyrylium probe: assays in cell cultures and peripheral blood |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |